Arcxis Biotech Raising Series B
Arcxis Biotechnologies, a Pleasanton, Calif.-based developer of pathogen detection devices for use in clinical molecular diagnostics, has held a first close on its Series B funding round. No financial terms were disclosed. Claremont Creek Ventures led the tranche, and was joined by Kaiser Permanente Ventures and Alafi Capital.
2 February 2009•3 mins read
